Chiusura precedente | 3,1500 |
Aperto | 3,0800 |
Denaro | 0,0000 x 46000 |
Lettera | 0,0000 x 27000 |
Min-Max giorno | 3,0000 - 3,2400 |
Intervallo di 52 settimane | 3,0000 - 17,4200 |
Volume | |
Media Volume | 23.387.115 |
Capitalizzazione | 1,558B |
Beta (5 anni mensile) | N/D |
Rapporto PE (ttm) | 9,00 |
EPS (ttm) | 0,3600 |
Prossima data utili | 26 lug 2022 - 01 ago 2022 |
Rendimento e dividendo (forward) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 15,20 |
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021. GATINEAU, Québec, July 05, 2022 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NASDAQ: HEXO) is pleased to announce that at its reconvened special meeting of shareholders held today (the "Meeting"), holders ("Shareholders") of common shares of HEX
LEAMINGTON, Ontario, June 29, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom. Tilray Medical now offers the broadest portfolio of cannabis flower in the UK market
Government of Luxembourg Visits Tilray Medical Cannabis Facility in Portugual Tilray Medical Hosts Luxembourg Delegation at Tilray's EU-GMP-certified medical cannabis facility in Portugal LISBON, Portugal, June 22, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, welcomes the Luxembourg Ministry o